Holen Sie sich die Stockscreener-App
63.37
0.72%
-0.46
Handel nachbörslich:
63.37
Schlusskurs vom Vortag:
$63.83
Offen:
$64.93
24-Stunden-Volumen:
604.61K
Relative Volume:
0.87
Marktkapitalisierung:
$2.92B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-146.66M
KGV:
-23.01
EPS:
-2.7541
Netto-Cashflow:
$-133.21M
1W Leistung:
+0.64%
1M Leistung:
+11.29%
6M Leistung:
+57.09%
1J Leistung:
+40.70%
1-Tages-Spanne:
$63.00
$67.66
1-Wochen-Bereich:
$61.15
$67.66
52-Wochen-Spanne:
$26.20
$67.66
Apogee Therapeutics Inc Stock (APGE) Company Profile
Firmenname
Apogee Therapeutics Inc
Sektor
Branche
Telefon
650-394-5230
Adresse
221 CRESCENT ST., WALTHAM
Vergleichen Sie APGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
63.37 | 4.36B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Eingeleitet | Craig Hallum | Buy |
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-07-07 | Bestätigt | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2024-11-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-10 | Eingeleitet | BofA Securities | Buy |
| 2023-12-20 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | Guggenheim | Buy |
| 2023-08-08 | Eingeleitet | Jefferies | Buy |
| 2023-08-08 | Eingeleitet | Stifel | Buy |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
| 2023-08-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Apogee Therapeutics stock hits 52-week high at $67.66 By Investing.com - Investing.com India
Is Apogee Therapeutics Inc. stock recession proofWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How to track smart money flows in Apogee Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
How to use Fibonacci retracement on Apogee Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Published on: 2025-11-15 19:11:00 - newser.com
Assessing Apogee Therapeutics (APGE) Valuation After Recent Surge in Investor Interest - Yahoo Finance
Why Apogee Therapeutics (APGE) Is Up 19.7% After Strong APG333 Trial Data and Cash Infusion - Yahoo Finance
Can volume confirm reversal in Apogee Therapeutics Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Is Apogee Therapeutics Inc a good long term investmentPrice Channel Trading & Learn the Basics of Investing in 5 Days - earlytimes.in
Insider Sell Alert: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock - Investing.com Canada
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock By Investing.com - Investing.com South Africa
[Form 4] Apogee Therapeutics, Inc. Insider Trading Activity - Stock Titan
Apogee Therapeutics CFO Sells 2,000 Shares - TradingView
CFO Henderson Sells 2,000 ($130K) Of Apogee Therapeutics Inc [APGE] - TradingView
APGE | Apogee Therapeutics Inc. SEC Filings - MarketWatch
Is Apogee Therapeutics Inc. stock positioned for digital transformation2025 Macro Impact & Daily Stock Momentum Reports - newser.com
Will Apogee Therapeutics Inc. stock remain a Wall Street favoriteWeekly Earnings Recap & Safe Capital Growth Tips - Fundação Cultural do Pará
Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment - MSN
Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
Apogee Therapeutics Insider Sold Shares Worth $1,260,236, According to a Recent SEC Filing - MarketScreener
Apogee Therapeutics CEO Henderson sells $1.26 million in stock By Investing.com - Investing.com Nigeria
Published on: 2025-11-13 23:54:39 - newser.com
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson, Apogee Therapeutics CFO, sells $60k in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CEO Henderson sells $1.26 million in stock - Investing.com India
Apogee Therapeutics Executives Sell Shares - TradingView
CFO Henderson Sells 1,000 ($60K) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Sells 20,000 ($1.3M) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Files To Sell 100,000 Of Apogee Therapeutics Inc [APGE] - TradingView
Apogee Therapeutics Reports Q3 2025 Financial Progress - MSN
Published on: 2025-11-12 14:24:11 - newser.com
Apogee Therapeutics stock hits 52-week high at 61.19 USD By Investing.com - Investing.com Nigeria
Is Apogee Therapeutics Inc. (APGE) Outperforming Other Medical Stocks This Year? - sharewise.com
Apogee Therapeutics’ Stock Surge: Is It Time To Jump In? - timothysykes.com
Apogee Therapeutics stock hits 52-week high at 61.19 USD - Investing.com India
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):